Xcout Intel
Nodal Therapeutics, Inc.
Nodal Therapeutics, Inc. is a biotechnology company seeking seed investment and co-development partnerships for its therapeutic pipeline.
Subscribe to see Nodal Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nodal Therapeutics, Inc. at a glance
Nodal Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $750,000 across the 2 funding rounds on record. Its most recent funding round, Seed, raised $500,000 in May 2026. Xcout tracks 7 named people at Nodal Therapeutics, Inc., including Christopher Jewell (Chief Executive Officer).
Nodal Therapeutics, Inc. leadership
- Christopher JewellChief Executive Officer
- Klaus MartinCEO
- Chris Sears, M.S.Chief Operating Officer
- Christopher M. Jewell, Ph.D.Founder
- Jonathan Bromberg, M.D., Ph.D.Co-Founder
- Lisa H. Tostanoski, Ph.D.Director, Translational Medicine
1 more named person on record for Nodal Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Nodal Therapeutics, Inc. funding rounds
At least $750,000 raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $500,000 | 2 named | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Nodal Therapeutics, Inc. competitors
A few of Nodal Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cirrus Therapeutics, Inc. is an early-stage biotechnology company that has raised seed funding for its therapeutic research operations.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Notable Labs, Inc. is a clinical-stage therapeutic platform company headquartered in Foster City, California. The company focuses on drug pipelines, patents, and clinical trials, and operates as a public company traded on NASDAQ under the ticker NTBL.
HDAX Therapeutics is a privately held, therapeutics-focused company that utilizes a next-generation targeting modality to unlock a novel binding mechanism to key biological molecules.
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
Oxalo Therapeutics, Inc. is a privately held biotechnology and therapeutics company founded in 2018 and based in Chicago, Illinois, dedicated to developing first-in-class treatments to treat and prevent disease targets.
Get Nodal Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nodal Therapeutics, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access